+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032- Product Image
Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032- Product Image
New

Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989693
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The enzyme-linked immunosorbent assay (ELISA) testing market stands as a reliable foundation for laboratory diagnostics and quality assurance within regulated and research-intensive settings. Senior decision-makers can leverage this synthesis to strategically align procurement, operational, and compliance objectives with current trends and specific market needs.

Market Snapshot: ELISA Testing Market

Driven by an expanding footprint in clinical diagnostics, pharmaceutical research, environmental monitoring, and the food industry, the global ELISA testing market is on a steady growth path. The market grew from USD 592.09 million in 2025 to USD 636.82 million in 2026, with a projected value of USD 971.88 million by 2032, achieving a CAGR of 7.33%. This trajectory is enabled by advancements in assay chemistry, laboratory instrumentation, and integrated data solutions, which collectively support more application-focused, flexible platforms for institutions worldwide. The adoption of ELISA solutions demonstrates lasting value for organizations seeking robust, repeatable, and regulatory-compliant testing outcomes.

Scope & Segmentation

  • Product Types: Microplate readers, washers, automated and manual kits, high-specificity antibodies, precision enzymes, diverse substrates, application-specialized software, and comprehensive maintenance services contribute to laboratory scalability and improved accuracy.
  • Assay Formats: Competitive, sandwich, direct, and indirect assays cater to unique analytical needs, providing laboratories with throughput optimization, increased sensitivity, and adaptability for specialized workflows.
  • End-User Segments: Academic institutions, contract research organizations, clinical laboratories, hospitals, pharmaceutical and biotechnology firms, and industrial testing facilities form the core market audience. Each segment faces distinct procurement priorities based on compliance expectations and operational scale.
  • Applications: Market uses range across disease diagnostics, pharmaceutical R&D, food quality assurance, and environmental safety monitoring, as ELISA platforms adapt to serve evolving industry mandates.
  • Regional Coverage: Americas, Europe Middle East & Africa, and Asia-Pacific each present different infrastructure environments, procurement strategies, and regulatory frameworks, directly influencing supplier choice, delivery models, and workflow implementation.
  • Technologies: Hardware platform integration, automated workflow compatibility, batch validation for critical reagents, advanced analytics software, and preventive service models all play roles in advancing laboratory output and safeguarding continuous operations.

Key Takeaways: Strategic Insights for Senior Leaders

  • Automation and integrated ELISA workflows are increasingly vital to improve laboratory throughput and reduce manual error, encouraging proactive investments in modular technologies.
  • Strengthening reagent validation and supply chain resilience can drive better compliance outcomes and reduce potential operational risks stemming from global supply fluctuations.
  • Analytics platforms paired with laboratory management systems support effective audits and enable real-time responsiveness in laboratory oversight, meeting the demand for agile management capabilities.
  • Procurement priorities vary by segment: academic settings favor adaptable, cost-efficient platforms, while hospitals and clinical labs require validated service levels to maintain continuity. Pharmaceutical organizations seek solutions that ensure automation and high compatibility to support demanding R&D cycles.
  • Scalable and standardized components, along with tailored maintenance provision, allow seamless adaptation from exploratory research to rigorous clinical routines, supporting diverse institutional profiles.
  • Regional requirements—such as infrastructure and responsiveness—are prompting solution providers to implement agile, locally adapted support for faster, reliable service delivery.

Tariff Impact and Sourcing Strategy

Shifts in United States tariff policies have increased sourcing complexity for the ELISA testing sector. Suppliers have responded by increasing domestic procurement of essential components or leveraging markets with advantageous trade agreements. These approaches not only safeguard supply continuity but also reduce lead times and mitigate risks associated with international logistics. In response, procurement specialists are updating vendor criteria to reflect changing landed costs, emphasize customs compliance, and anticipate lead-time variability. Choosing service contracts that guarantee local support and routine preventive maintenance is increasingly seen as central to risk management in laboratory operations.

Methodology & Data Sources

This market analysis draws directly from interviews with laboratory directors, procurement leads, research scientists, and technical managers to clarify key buying drivers and workflow hurdles. Secondary validation comes from published scientific studies, regulatory data, and verified manufacturer sources. All content is peer-checked and subject to expert review to maintain current accuracy and relevance for the ELISA testing market.

Why This Report Matters

  • Offers actionable benchmarking for leadership teams to optimize ELISA procurement, scaling, and compliance within their distinct operational settings.
  • Presents an at-a-glance supplier evaluation guide, highlighting integration across instruments, consumables, and digital platforms to increase lab efficiency and confidence in procurement decisions.
  • Delivers pragmatic, supply-chain-focused recommendations for leaders navigating global sourcing, market-specific regulation, and evolving laboratory requirements.

Conclusion

Enhancements in ELISA testing solutions and procurement frameworks now position laboratories to improve efficiency, scalability, and compliance. Senior leaders can utilize this analysis to inform robust, flexible strategies for sustainable success in laboratory management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Enzyme-linked Immunosorbent Assay Testing Market, by Product
8.1. Instruments
8.1.1. Microplate Readers
8.1.2. Microplate Washers
8.2. Kits
8.2.1. Automated Kits
8.2.2. Manual Kits
8.3. Reagents
8.3.1. Antibodies
8.3.2. Enzymes
8.3.3. Substrates
8.4. Software And Services
8.4.1. Data Analysis Software
8.4.2. Maintenance Services
9. Enzyme-linked Immunosorbent Assay Testing Market, by Assay Type
9.1. Competitive
9.2. Direct
9.3. Indirect
9.4. Sandwich
10. Enzyme-linked Immunosorbent Assay Testing Market, by Application
10.1. Disease Testing
10.2. Drug Discovery
10.3. Environmental Testing
10.4. Food Safety And Quality
11. Enzyme-linked Immunosorbent Assay Testing Market, by End Users
11.1. Academic And Research
11.2. Contract Research Organizations
11.3. Hospitals And Diagnostics
11.4. Pharmaceutical And Biotech
12. Enzyme-linked Immunosorbent Assay Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Enzyme-linked Immunosorbent Assay Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Enzyme-linked Immunosorbent Assay Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Enzyme-linked Immunosorbent Assay Testing Market
16. China Enzyme-linked Immunosorbent Assay Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abcam plc
17.6. Abnova Corporation
17.7. Bio-Rad Laboratories, Inc.
17.8. Biolegend, Inc.
17.9. BioVendor-Laboratorní Systémy s.r.o.
17.10. Boster Biological Technology Co., Ltd.
17.11. Calbiotech, Inc.
17.12. Cusabio Technology Co., Ltd.
17.13. DiaSorin S.p.A.
17.14. DRG International, Inc.
17.15. Elabscience Biotechnology Co., Ltd.
17.16. Enzo Life Sciences, Inc.
17.17. Merck KGaA
17.18. MyBioSource, Inc.
17.19. PerkinElmer, Inc.
17.20. R&D Systems, a brand of Bio-Techne Corporation
17.21. RayBiotech, Inc.
17.22. Sino Biological, Inc.
17.23. Thermo Fisher Scientific, Inc.
List of Figures
FIGURE 1. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE WASHERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE WASHERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MICROPLATE WASHERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBSTRATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBSTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY FOOD SAFETY AND QUALITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY FOOD SAFETY AND QUALITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY FOOD SAFETY AND QUALITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 126. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 128. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 142. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 143. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 144. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 145. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 146. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 161. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 162. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 163. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 165. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 168. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 170. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 171. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 172. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 173. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 174. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 175. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 186. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 188. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 189. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 190. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 191. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 192. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 193. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 195. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 197. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 198. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 199. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 200. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 201. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 202. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 204. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 206. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 207. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 208. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 209. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 210. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 211. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 223. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 225. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 226. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 227. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 228. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 229. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 230. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Enzyme-linked Immunosorbent Assay Testing market report include:
  • Abcam plc
  • Abnova Corporation
  • Bio-Rad Laboratories, Inc.
  • Biolegend, Inc.
  • BioVendor-Laboratorní Systémy s.r.o.
  • Boster Biological Technology Co., Ltd.
  • Calbiotech, Inc.
  • Cusabio Technology Co., Ltd.
  • DiaSorin S.p.A.
  • DRG International, Inc.
  • Elabscience Biotechnology Co., Ltd.
  • Enzo Life Sciences, Inc.
  • Merck KGaA
  • MyBioSource, Inc.
  • PerkinElmer, Inc.
  • R&D Systems, a brand of Bio-Techne Corporation
  • RayBiotech, Inc.
  • Sino Biological, Inc.
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 636.82 Million
Forecasted Market Value ( USD ) by 2032 $ 971.88 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2026-2032 - Product Image

Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay Testing Market Report 2025 - Product Image

Enzyme-Linked Immunosorbent Assay Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Enzyme Linked Immunosorbent Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Enzyme Linked Immunosorbent Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Enzyme Linked Immunosorbent Assay Test Market

The Enzyme Linked Immunosorbent Assay (ELISA) Test is a type of In Vitro Diagnostics (IVD) test used to detect and measure the presence of antibodies, antigens, and other proteins in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of hormones, toxins, and other substances in the body. The ELISA Test market is a rapidly growing segment of the IVD market. ELISA tests are used in a variety of clinical settings, including hospitals, laboratories, and research facilities. The market is driven by the increasing demand for accurate and reliable diagnostic tests, as well as the development of new technologies and products. Some of the major companies in the ELISA Test market include Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.